The industry’s response to national pharmacare

Pharmacare is a system of health insurance that covers necessary prescription medications for all Canadians, regardless of where they work or whether they have an existing drug plan.

Members of the National Pharmacare Advisory Council submitted an interim report to the federal government on the implementation of pharmacare at the national level. In the report, the council set out three initial recommendations:

  • Create a national drug agency to oversee national pharmacare
  • Develop a comprehensive list of prescribed drugs to harmonize coverage
  • Invest in data on prescription medications and technologies

The Canadian Life and Health Insurance Association (CLHIA) believes that implementing a national pharmacare system requires a collaborative effort across insurers, provincial and territorial governments as well the federal government.

The CLHIA has made recommendations of their own to the federal government, which include the following:

  • Ensure that current plans are both protected and enhanced
  • Ensure that the federal government works with the industry to make sure that a national plan is sustainable and affordable for taxpayers
  • Establish a list of medications that everyone should be covered for (including rare and expensive drugs when required)

The CLHIA concludes that a national pharmacare model should work to achieve a sustainable plan that would ensure that no Canadian sees diminished coverage and that improvements benefit all Canadians.

We continue to monitor developments on how this may impact our Group Benefit plans.

New EI parental sharing benefit

Learn about the new EI sharing benefit, made effective March 17, 2019.